The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Sterilization and decontamination technology firm Steris Corp. (NYSE:STE) opened a new European headquarters in Bordeaux, France.
In the 85,000 square-foot facility, Steris combined marketing, manufacturing, sales, costumer service and research & development.
Philips Healthcare (NYSE:PHG) said it plans to move 100 jobs to a Highland Heights, Ohio-based research & development facility as it cuts back at its nuclear medicine arm in San Jose, Calif.
The Dutch subsidiary in 2006 moved its nuclear medicine HQ from California to the Ohio location, where the company currently employs 1,200.
MASSDEVICE ON CALL — Sister companies Raytel Cardiac Services Inc. and Philips Remote Cardiac Services plan to cut 85 jobs from a cardiac monitoring unit in Windsor, Conn.
The companies plan to cut work related to cardiac monitoring of pacemakers, but will keep 200 employees primarily focused on monitoring irregular heartbeats.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
C.R. Bard Inc. (NYSE:BCR) plans to cut 50 jobs from its Queensbury, N.Y.-based manufacturing plant.
The 50 positions could be relocated outside the U.S., according to the Glen Falls, N.Y.-based Post Star. That would leave the Queensbury plant with roughly 770 employees.
Abbott Laboratories (NYSE:ABT) is laying off a total of 160 jobs in its diagnostics operation, continuing a streamlining effort it launched in 2008.
The cuts include 10 jobs at the health care conglomerate’s Chicago headquarters and about 150 positions at a plant in Santa Clara, Calif., according to the Chicago Tribune.
Wright Medical Group Inc. (NSDQ:WMGI) is cutting 80 positions, or about 6 percent of its total workforce, in a move aimed at raising its earnings per share, the Arlington, Tenn.-based orthopedic device maker said today.
The plan, initially slated to roll out over the next nine months, will see Wright try to re-shape its international operations, scaling back the products it offers overseas and "streamlining select aspects of its international selling and distribution operations," according to a press release.
ARLINGTON, Tenn.–(BUSINESS WIRE)–Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical
device company and a leading provider of surgical solutions for the foot
and ankle market, announced today that it is implementing a cost
restructuring plan to foster growth, enhance profitability and cash
flow, and build shareholder value. Wright Medical expects that the
initial phase of this plan will be completed during the next nine
months, with additional efficiency initiatives to be implemented
throughout 2012 and beyond.
Medtronic Inc. (NYSE:MDT) is looking to eliminate about 700 more jobs by the end of its current fiscal year through layoffs and early retirement offers, according to regulatory documents.
The moves are part of a restructuring initiative the company announced in February to reduce its global workforce by 5 percent.
Officials at World Heart Corp. (NSDQ:WHRT) officially pulled the plug on clinical trials of the company’s Levacor ventricular assist device (VAD) technology and laid off nearly half its workforce.
Histogenics Corp., fresh from a merger with fellow Bay State firm Prochon Biotech, has no plans for layoffs, contrary to a report in an Israeli journal.
The Globes new outlet, a business daily based in Rishon Le-Zion, Israel, reported yesterday that Histogenics "will make substantial cuts" to its R&D unit in Ness Ziona.
